Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT AUROBINDO PHARMA WOCKHARDT/
AUROBINDO PHARMA
 
P/E (TTM) x -15.8 23.0 - View Chart
P/BV x 2.5 2.4 105.9% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 WOCKHARDT   AUROBINDO PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
AUROBINDO PHARMA
Mar-23
WOCKHARDT/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs316715 44.2%   
Low Rs145397 36.6%   
Sales per share (Unadj.) Rs184.0424.2 43.4%  
Earnings per share (Unadj.) Rs-43.132.9 -131.0%  
Cash flow per share (Unadj.) Rs-25.754.1 -47.4%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs231.7458.1 50.6%  
Shares outstanding (eoy) m144.09585.94 24.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.3 95.6%   
Avg P/E ratio x-5.316.9 -31.6%  
P/CF ratio (eoy) x-9.010.3 -87.4%  
Price / Book Value ratio x1.01.2 82.0%  
Dividend payout %09.1 -0.0%   
Avg Mkt Cap Rs m33,202325,753 10.2%   
No. of employees `000NANA-   
Total wages/salary Rs m6,37035,223 18.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26,510248,554 10.7%  
Other income Rs m1,2202,906 42.0%   
Total revenues Rs m27,730251,460 11.0%   
Gross profit Rs m-1,93037,070 -5.2%  
Depreciation Rs m2,51012,446 20.2%   
Interest Rs m3,0201,405 215.0%   
Profit before tax Rs m-6,24026,125 -23.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-306,849 -0.4%   
Profit after tax Rs m-6,21019,277 -32.2%  
Gross profit margin %-7.314.9 -48.8%  
Effective tax rate %0.526.2 1.8%   
Net profit margin %-23.47.8 -302.0%  
BALANCE SHEET DATA
Current assets Rs m19,140214,599 8.9%   
Current liabilities Rs m34,350114,938 29.9%   
Net working cap to sales %-57.440.1 -143.1%  
Current ratio x0.61.9 29.8%  
Inventory Days Days3921 191.0%  
Debtors Days Days1166 16.7%  
Net fixed assets Rs m48,670176,668 27.5%   
Share capital Rs m720586 122.9%   
"Free" reserves Rs m32,660267,813 12.2%   
Net worth Rs m33,380268,399 12.4%   
Long term debt Rs m2,2406,190 36.2%   
Total assets Rs m70,750392,125 18.0%  
Interest coverage x-1.119.6 -5.4%   
Debt to equity ratio x0.10 291.0%  
Sales to assets ratio x0.40.6 59.1%   
Return on assets %-4.55.3 -85.5%  
Return on equity %-18.67.2 -259.0%  
Return on capital %-9.010.0 -90.2%  
Exports to sales %033.7 0.0%   
Imports to sales %3.515.3 22.7%   
Exports (fob) Rs mNA83,703 0.0%   
Imports (cif) Rs m92038,060 2.4%   
Fx inflow Rs m73085,483 0.9%   
Fx outflow Rs m92041,447 2.2%   
Net fx Rs m-19044,036 -0.4%   
CASH FLOW
From Operations Rs m1,53023,868 6.4%  
From Investments Rs m-1,250-39,778 3.1%  
From Financial Activity Rs m-3,15018,144 -17.4%  
Net Cashflow Rs m-2,8002,298 -121.9%  

Share Holding

Indian Promoters % 54.9 48.8 112.7%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 4.5 41.3 10.8%  
FIIs % 4.2 20.7 20.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 48.2 93.6%  
Shareholders   161,813 241,944 66.9%  
Pledged promoter(s) holding % 74.5 20.1 370.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Wockhardt vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Wockhardt vs Aurobindo Pharma Share Price Performance

Period Wockhardt Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 4.99% 1.82% 1.18%
1-Month 0.15% 5.96% -0.75%
1-Year 290.07% 113.07% 61.82%
3-Year CAGR 13.79% 7.78% 18.16%
5-Year CAGR 7.92% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Wockhardt share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Wockhardt hold a 54.9% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Wockhardt, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.